BIOMAT Database Logo BIOMAT Database Logo

HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. 2003

Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
Department of Genetics and Pathology, Uppsala University, and Cavidi Tech AB, Uppsala Science Park, SE-751 83 Uppsala, Sweden. anders@cavidi.se

We describe a procedure (ExaVir Load) to carry out human immunodeficiency virus-1 (HIV-1) viral load testing using reverse transcriptase (RT) recovered from HIV-1 virions in plasma. Samples from individuals infected with HIV-1 were treated with a sulphydryl-reactive agent to inactivate endogenous polymerases. Virions were then immobilised on a gel and washed in individual mini columns to remove RT-inhibiting antibodies, antiviral drugs, and other RT inhibitors. Immobilised virions were lysed finally, and the viral RT eluted. The amount of RT recovered was quantified by a sensitive RT activity assay using either colorimetry or fluorimetry to detect DNA produced by RT. The "RT load" values of 390 samples from 302 HIV-1 patients living in Sweden were compared to results obtained with an HIV-1 RNA viral load assay. The correlation between the two tests was r = 0.90, P < 0.0001. Four of 202 samples from healthy blood donors gave low positive values in the RT test. All samples in a panel with 10 HIV-1 subtypes were positive by the RT load. The RT load test provides a technically less demanding and cost-effective alternative to methods based on nucleic acid amplification. Being insensitive to genetic drift occurring in HIV, the assay should be of particular use in resource-limited settings, where different subtypes and recombinant HIV strains occur.

UI MeSH Term Description Entries
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D004228 Dithionitrobenzoic Acid A standard reagent for the determination of reactive sulfhydryl groups by absorbance measurements. It is used primarily for the determination of sulfhydryl and disulfide groups in proteins. The color produced is due to the formation of a thio anion, 3-carboxyl-4-nitrothiophenolate. 5,5'-Dithiobis(2-nitrobenzoic Acid),DTNB,Ellman's Reagent,5,5'-Dithiobis(nitrobenzoate),Acid, Dithionitrobenzoic,Ellman Reagent,Ellmans Reagent,Reagent, Ellman's
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014771 Virion The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos. Virus Particle,Viral Particle,Viral Particles,Particle, Viral,Particle, Virus,Particles, Viral,Particles, Virus,Virions,Virus Particles
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
[Quantification of HIV-1 viral load by the measurement of reverse transcriptase activity].
April 1998, Medicina clinica,
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring.
April 2005, Current HIV research,
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays.
January 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load.
May 1997, Lancet (London, England),
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
HIV reverse transcriptase activity assay: a feasible surrogate for HIV viral load measurement in China.
November 2010, Diagnostic microbiology and infectious disease,
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
The performance of reverse transcriptase assay for the estimation of the plasma viral load in HIV-1 and HIV-2 infections.
January 2016, Infectious diseases (London, England),
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
Comparative evaluation of a reverse transcriptase based assay for HIV-1 viral load quantitation in resource limited settings.
July 2014, Journal of virological methods,
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
Structure based activity prediction of HIV-1 reverse transcriptase inhibitors.
March 2005, Journal of medicinal chemistry,
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
Use of reverse-transcriptase-based HIV-1 viral load assessment to confirm low viral loads in newly diagnosed patients in Switzerland.
February 2014, BMC infectious diseases,
Anders Malmsten, and Xing-Wu Shao, and Kajsa Aperia, and Gary E Corrigan, and Eric Sandström, and Clas F R Källander, and Thomas Leitner, and J Simon Gronowitz
A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes.
February 2003, AIDS (London, England),
Copied contents to your clipboard!